Together, these data support the idea that VNS attenuates HMGB1 levels and affects the colonic immune response, mainly reducing IL-6 and CXCL1 production in oxazolone-induced colitis eventually leading to an improved survival. The gene discussed is CXCL1; the disease is colitis.